Overview
Cohero Health, now part of the Aptar Digital Health ecosystem in 2026, provides a comprehensive digital therapeutic platform specifically designed for chronic respiratory diseases like Asthma and COPD. The architecture integrates hardware and software through the HeroTracker® smart sensors and mobile spirometers, which connect via Bluetooth Low Energy (BLE) to the BreatheSmart mobile application. This technical ecosystem captures real-time medication usage data and lung function metrics (FEV1/FVC), syncing them to a HIPAA-compliant cloud environment. The platform leverages predictive analytics to identify early signs of patient deterioration, allowing for proactive clinical intervention. In the 2026 market, Cohero stands out for its high-fidelity data integration into existing clinical workflows via HL7 and FHIR protocols, making it a staple for clinical trials and large-scale population health management. By closing the loop between patient behavior and clinical outcomes, the platform optimizes medication adherence—often reaching levels 2-3x higher than the industry average—while reducing emergency room visits and healthcare utilization costs for enterprise stakeholders.